2/14/2022 | BK | Market Commentary: Covis Pharma breaks; BCP updated; Olaplex, NAPA, Cast & Crew, CTC accelerate deadlines
|
2/11/2022 | BK | Market Commentary: Garda, Knot, Foley Products, East West break; Culligan updated; Del Monte accelerated
|
2/11/2022 | BK | Covis Pharma widens U.S. and euro first-lien term loans OID to 90
|
2/7/2022 | BK | Market Commentary: Ontic breaks; Covis revised; Ufinet, Virtusa accelerate deadlines; Culligan, NAPA set talk
|
2/7/2022 | BK | Covis Pharma upsizes first- and second-liens loans, adds euro loan
|
1/31/2022 | BK | Market Commentary: XLerate, Syniverse break; Covis, Ankura tweak deals; Scientific Games, Bakelite accelerated
|
1/31/2022 | BK | Covis Pharma lifts term B to $550 million, adds second-lien loan
|
1/28/2022 | BKCVDDEMIGPV | Market Commentary: ION, Covis on hold; volatile junk market ends day up, week down; athenahealth struggles
|
1/19/2022 | BKHY | S&P assigns B to Covis notes
|
1/11/2022 | BK | Covis Pharma schedules deep dive lender call for Thursday
|
1/10/2022 | BK | Market Commentary: TricorBraun tweaks deal; Micro Focus, Griffon, Covis, Trac, Maravai, Simply disclose talk
|
1/10/2022 | BK | Covis Pharma launches $350 million term loan B at SOFR plus 625 bps
|
1/10/2022 | BK | S&P rates Covis, loan B
|
1/7/2022 | BK | Market Commentary: Virtu, Dun & Bradstreet break for trading; TricorBraun moves deadline; Vaco sets talk
|
1/7/2022 | BK | Covis Pharma to launch $350 million term loan B on Monday
|
5/15/2015 | BKBWCAHY | Concordia ends Q1 with $35 million cash, completes Covis acquisition
|
3/10/2015 | BK | Moody's reviews Covis Pharma
|
4/11/2014 | BK | Moody's: Covis Pharma view positive
|
4/24/2013 | BK | Market Commentary: 24 Hour, Covis break; SourceHOV, Harland Clarke, CDW, Caraustar, Harden, Truven tweak deals
|
4/22/2013 | BK | Market Commentary: Delta, U.S. Shipping, Osmose, EveryWare, Advantage Sales break; Lineage, Caraustar up deadlines
|
4/22/2013 | BK | Covis Pharma flexes $205 million term loan to Libor plus 475 bps
|
4/17/2013 | BK | Market Commentary: Securus Technologies, Regal Cinemas break; UPC, TriNet rework deals; Covis shutting early
|
4/10/2013 | BK | S&P rates Covis Pharma loans B
|
4/10/2013 | BK | Moody's: Covis Pharma loans B3
|
4/8/2013 | BK | Covis Pharma launches $205 million term loan at Libor plus 525-550 bps
|
4/8/2013 | BK | Market Commentary: Sinclair, Belfor, Mirion break; Charter, Evertec, Rice Drilling, Steward, Ranpak tweak deals
|
4/4/2013 | BK | Covis Pharma to launch $230 million credit facility on Monday
|
4/4/2013 | BK | Market Commentary: SRAM, Hertz break; ABC Supply, Cooper Gay, First Data, Cenveo, Seminole Tribe tweak deals
|